Published in Arch Gen Psychiatry on June 01, 2001
Brain structural and functional abnormalities in mood disorders: implications for neurocircuitry models of depression. Brain Struct Funct (2008) 6.32
Neurocircuitry of mood disorders. Neuropsychopharmacology (2010) 5.57
Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders. Nat Rev Drug Discov (2008) 4.46
Reconsidering anhedonia in depression: lessons from translational neuroscience. Neurosci Biobehav Rev (2010) 3.46
The subgenual anterior cingulate cortex in mood disorders. CNS Spectr (2008) 3.40
Cellular changes in the postmortem hippocampus in major depression. Biol Psychiatry (2004) 2.54
Bipolar and major depressive disorder: neuroimaging the developmental-degenerative divide. Neurosci Biobehav Rev (2009) 2.44
Glial pathology in an animal model of depression: reversal of stress-induced cellular, metabolic and behavioral deficits by the glutamate-modulating drug riluzole. Mol Psychiatry (2008) 2.42
Gliogenesis and glial pathology in depression. CNS Neurol Disord Drug Targets (2007) 2.26
A molecular signature of depression in the amygdala. Am J Psychiatry (2009) 2.18
Glial loss in the prefrontal cortex is sufficient to induce depressive-like behaviors. Biol Psychiatry (2008) 2.14
Peripheral BDNF produces antidepressant-like effects in cellular and behavioral models. Neuropsychopharmacology (2010) 1.81
Mechanisms of synapse and dendrite maintenance and their disruption in psychiatric and neurodegenerative disorders. Annu Rev Neurosci (2010) 1.68
Reduced levels of NR2A and NR2B subunits of NMDA receptor and PSD-95 in the prefrontal cortex in major depression. Prog Neuropsychopharmacol Biol Psychiatry (2008) 1.54
Glutamatergic and resting-state functional connectivity correlates of severity in major depression - the role of pregenual anterior cingulate cortex and anterior insula. Front Syst Neurosci (2010) 1.54
Brain-derived neurotrophic factor: role in depression and suicide. Neuropsychiatr Dis Treat (2009) 1.48
Molecular evidence for BDNF- and GABA-related dysfunctions in the amygdala of female subjects with major depression. Mol Psychiatry (2011) 1.48
Molecular mechanisms of dendrite stability. Nat Rev Neurosci (2013) 1.44
Adenylate cyclase 7 is implicated in the biology of depression and modulation of affective neural circuitry. Biol Psychiatry (2012) 1.43
Neuroinflammation and psychiatric illness. J Neuroinflammation (2013) 1.42
Mitochondrial-related gene expression changes are sensitive to agonal-pH state: implications for brain disorders. Mol Psychiatry (2006) 1.38
GABA-related transcripts in the dorsolateral prefrontal cortex in mood disorders. Int J Neuropsychopharmacol (2011) 1.38
Anatomical abnormalities of the anterior cingulate cortex in schizophrenia: bridging the gap between neuroimaging and neuropathology. Schizophr Bull (2008) 1.37
Age-dependent reductions in the level of glial fibrillary acidic protein in the prefrontal cortex in major depression. Neuropsychopharmacology (2004) 1.36
Astrocyte-derived ATP modulates depressive-like behaviors. Nat Med (2013) 1.35
Gene expression profiling in postmortem prefrontal cortex of major depressive disorder. J Neurosci (2007) 1.30
Differential regulation of central BDNF protein levels by antidepressant and non-antidepressant drug treatments. Brain Res (2008) 1.28
Ketamine decreases resting state functional network connectivity in healthy subjects: implications for antidepressant drug action. PLoS One (2012) 1.27
Astrocyte pathology in major depressive disorder: insights from human postmortem brain tissue. Curr Drug Targets (2013) 1.26
Activation of mammalian target of rapamycin and synaptogenesis: role in the actions of rapid-acting antidepressants. Biol Psychiatry (2013) 1.26
Dynamic microglial alterations underlie stress-induced depressive-like behavior and suppressed neurogenesis. Mol Psychiatry (2013) 1.26
Implications of adult hippocampal neurogenesis in antidepressant action. J Psychiatry Neurosci (2004) 1.24
Prominent reduction in pyramidal neurons density in the orbitofrontal cortex of elderly depressed patients. Biol Psychiatry (2005) 1.24
Glia pathology in the prefrontal cortex in alcohol dependence with and without depressive symptoms. Biol Psychiatry (2002) 1.22
From pathophysiology to novel antidepressant drugs: glial contributions to the pathology and treatment of mood disorders. Biol Psychiatry (2013) 1.21
Neural circuitry and neuroplasticity in mood disorders: insights for novel therapeutic targets. NeuroRx (2006) 1.19
Neuropathology of stress. Acta Neuropathol (2013) 1.14
Abnormalities of cingulate gyrus neuroanatomy in schizophrenia. Schizophr Res (2007) 1.13
Valproate and amitriptyline exert common and divergent influences on global and gene promoter-specific chromatin modifications in rat primary astrocytes. Neuropsychopharmacology (2009) 1.12
Frontal white matter anisotropy and antidepressant remission in late-life depression. PLoS One (2008) 1.09
Neurovascular unit dysfunction with blood-brain barrier hyperpermeability contributes to major depressive disorder: a review of clinical and experimental evidence. J Neuroinflammation (2013) 1.08
Targeting glutamatergic signaling for the development of novel therapeutics for mood disorders. Curr Pharm Des (2009) 1.08
Glial and glutamatergic markers in depression, alcoholism, and their comorbidity. J Affect Disord (2010) 1.06
Illness progression, recent stress, and morphometry of hippocampal subfields and medial prefrontal cortex in major depression. Biol Psychiatry (2014) 1.06
Expression of CB1 cannabinoid receptor in the anterior cingulate cortex in schizophrenia, bipolar disorder, and major depression. J Neural Transm (Vienna) (2007) 1.05
Neuroplasticity as a target for the pharmacotherapy of anxiety disorders, mood disorders, and schizophrenia. Drug Discov Today (2009) 1.05
A putative functional role for oligodendrocytes in mood regulation. Transl Psychiatry (2012) 1.02
Gap junction dysfunction in the prefrontal cortex induces depressive-like behaviors in rats. Neuropsychopharmacology (2011) 1.02
Region-of-interest-based analysis with application of cortical thickness variation of left planum temporale in schizophrenia and psychotic bipolar disorder. Hum Brain Mapp (2008) 1.00
Cingulate gyrus neuroanatomy in schizophrenia subjects and their non-psychotic siblings. Schizophr Res (2008) 1.00
Blockade of astrocytic glutamate uptake in rats induces signs of anhedonia and impaired spatial memory. Neuropsychopharmacology (2010) 1.00
Evidence for Alteration of Gene Regulatory Networks through MicroRNAs of the HIV-infected brain: novel analysis of retrospective cases. PLoS One (2010) 1.00
Remodeling of axo-spinous synapses in the pathophysiology and treatment of depression. Neuroscience (2012) 0.99
Glutamate and its receptors in the pathophysiology and treatment of major depressive disorder. J Neural Transm (Vienna) (2013) 0.98
Decreased BDNF and TrkB mRNA expression in multiple cortical areas of patients with schizophrenia and mood disorders. Transl Psychiatry (2014) 0.98
Construction and analysis of the protein-protein interaction networks for schizophrenia, bipolar disorder, and major depression. BMC Bioinformatics (2011) 0.98
The As and Ds of stress: metabolic, morphological and behavioral consequences. Eur J Pharmacol (2008) 0.98
Markers of glutamate synaptic transmission and plasticity are increased in the anterior cingulate cortex in bipolar disorder. Biol Psychiatry (2010) 0.97
Astrocyte heterogeneity in the brain: from development to disease. Front Cell Neurosci (2015) 0.97
Altered volume and hemispheric asymmetry of the superficial cortical layers in the schizophrenia planum temporale. Eur J Neurosci (2009) 0.96
Postmortem evidence of cerebral inflammation in schizophrenia: a systematic review. Mol Psychiatry (2016) 0.96
Cortical expression of glial fibrillary acidic protein and glutamine synthetase is decreased in schizophrenia. Schizophr Res (2008) 0.96
Neuroinflammation, neurodegeneration, and depression. Neurotox Res (2012) 0.95
Sex differences in the effects of acute and chronic stress and recovery after long-term stress on stress-related brain regions of rats. Cereb Cortex (2008) 0.94
Serum S100B represents a new biomarker for mood disorders. Curr Drug Targets (2013) 0.94
Low nNOS protein in the locus coeruleus in major depression. J Neurochem (2004) 0.94
The impact of vascular burden on late-life depression. Brain Res Rev (2009) 0.94
Evidence demonstrating role of microRNAs in the etiopathology of major depression. J Chem Neuroanat (2011) 0.94
A morphometric analysis of the septal nuclei in schizophrenia and affective disorders: reduced neuronal density in the lateral septal nucleus in bipolar disorder. Eur Arch Psychiatry Clin Neurosci (2010) 0.93
Integrated neurobiology of bipolar disorder. Front Psychiatry (2014) 0.93
Mood disorders are glial disorders: evidence from in vivo studies. Cardiovasc Psychiatry Neurol (2010) 0.93
Large-scale estimates of cellular origins of mRNAs: enhancing the yield of transcriptome analyses. J Neurosci Methods (2007) 0.93
Depression and treatment response: dynamic interplay of signaling pathways and altered neural processes. Cell Mol Life Sci (2012) 0.93
Astrocyte decrease in the subgenual cingulate and callosal genu in schizophrenia. Eur Arch Psychiatry Clin Neurosci (2012) 0.92
Neural stem cell regulation, fibroblast growth factors, and the developmental origins of neuropsychiatric disorders. Front Neurosci (2010) 0.92
Glia mechanisms in mood regulation: a novel model of mood disorders. Psychopharmacology (Berl) (2007) 0.92
Mitochondrial dysfunction, oxidative stress, and major depressive disorder. Neuropsychiatr Dis Treat (2013) 0.92
A morphometric, immunohistochemical, and in situ hybridization study of the dorsal raphe nucleus in major depression, bipolar disorder, schizophrenia, and suicide. J Affect Disord (2011) 0.92
Hippocampal neurogenesis and antidepressive therapy: shocking relations. Neural Plast (2014) 0.91
Acute D-serine treatment produces antidepressant-like effects in rodents. Int J Neuropsychopharmacol (2011) 0.90
Altered gene synchrony suggests a combined hormone-mediated dysregulated state in major depression. PLoS One (2010) 0.90
Advances in the treatment of anxiety: targeting glutamate. NeuroRx (2006) 0.90
Glial fibrillary acidic protein in late life major depressive disorder: an immunocytochemical study. J Neurol Neurosurg Psychiatry (2002) 0.90
Effects of lithium on inflammation. ACS Chem Neurosci (2014) 0.89
Chronic psychosocial stress and citalopram modulate the expression of the glial proteins GFAP and NDRG2 in the hippocampus. Psychopharmacology (Berl) (2012) 0.89
Hemichannels: new roles in astroglial function. Front Physiol (2014) 0.89
Mourning and melancholia revisited: correspondences between principles of Freudian metapsychology and empirical findings in neuropsychiatry. Ann Gen Psychiatry (2008) 0.89
Unchanged packing density but altered size of neurofilament immunoreactive neurons in the prefrontal cortex in schizophrenia and major depression. Schizophr Res (2005) 0.87
DNA fragmentation is increased in non-GABAergic neurons in bipolar disorder but not in schizophrenia. Schizophr Res (2007) 0.87
Comparison of prefrontal cell pathology between depression and alcohol dependence. J Psychiatr Res (2003) 0.87
Chronic stress and brain plasticity: Mechanisms underlying adaptive and maladaptive changes and implications for stress-related CNS disorders. Neurosci Biobehav Rev (2015) 0.86
Neurobiology of major depressive disorder. Neural Plast (2013) 0.86
Abnormal expression of glutamate transporters in temporal lobe areas in elderly patients with schizophrenia. Schizophr Res (2013) 0.86
Gene expression in the anterior cingulate cortex and amygdala of adolescent marmoset monkeys following parental separations in infancy. Int J Neuropsychopharmacol (2008) 0.86
Neuroprotective effects of antidepressant and mood stabilizing drugs. J Psychiatry Neurosci (2002) 0.86
Emerging role of microRNAs in major depressive disorder: diagnosis and therapeutic implications. Dialogues Clin Neurosci (2014) 0.85
Alcohol dependence-related increase of glial cell density in the anterior cingulate cortex of suicide completers. J Psychiatry Neurosci (2009) 0.85
Effects of neonatal flutamide treatment on hippocampal neurogenesis and synaptogenesis correlate with depression-like behaviors in preadolescent male rats. Neuroscience (2010) 0.85
Biomarkers of epileptogenesis: psychiatric comorbidities (?). Neurotherapeutics (2014) 0.85
Cell number and neuropil alterations in subregions of the anterior hippocampus in a female monkey model of depression. Biol Psychiatry (2013) 0.85
A missense mutation in the human connexin50 gene (GJA8) underlies autosomal dominant "zonular pulverulent" cataract, on chromosome 1q. Am J Hum Genet (1998) 3.64
Association between clozapine response and allelic variation in 5-HT2A receptor gene. Lancet (1995) 3.08
The membrane spanning domain of beta-1,4-galactosyltransferase specifies trans Golgi localization. EMBO J (1991) 2.46
Amisulpride augmentation of clozapine: an open non-randomized study in patients with schizophrenia partially responsive to clozapine. Acta Psychiatr Scand (2004) 2.24
Contaminants in the Canadian Arctic: 5 years of progress in understanding sources, occurrence and pathways. Sci Total Environ (2000) 2.16
Active monitoring of 12,760 clozapine recipients in the UK and Ireland. Beyond pharmacovigilance. Br J Psychiatry (1999) 2.14
Continuous variation of agonist affinity constants. Trends Pharmacol Sci (1988) 2.14
A structural equation modeling investigation of age-related variance in executive function and DTI measured white matter damage. Neurobiol Aging (2007) 1.92
An analysis of functional antagonism and synergism. Br J Pharmacol (1981) 1.89
Clinical and genetic heterogeneity in autosomal dominant cataract. Br J Ophthalmol (1999) 1.77
Detection of the human immunodeficiency virus regulatory protein tat in CNS tissues. J Neurovirol (2000) 1.71
Peer reviewed: tracking the distribution of persistent organic pollutants. Environ Sci Technol (1996) 1.70
Dopamine receptors in the central thermoregulatory pathways of the rat. J Physiol (1978) 1.70
The zig-zag tracheal strip. J Pharm Pharmacol (1979) 1.61
Connexin 50 mutation in a family with congenital "zonular nuclear" pulverulent cataract of Pakistani origin. Hum Genet (1999) 1.54
Molecular mechanism underlying a Cx50-linked congenital cataract. Am J Physiol (1999) 1.53
Reduced expression of the muscarinic 1 receptor cortical subtype in schizophrenia. Am J Med Genet B Neuropsychiatr Genet (2003) 1.52
A randomized controlled trial with 4-month follow-up of adjunctive repetitive transcranial magnetic stimulation of the left prefrontal cortex for depression. Psychol Med (2007) 1.49
Association analysis of the catechol O-methyltransferase gene and bipolar affective disorder. Am J Psychiatry (1997) 1.47
Connexin46 mutations linked to congenital cataract show loss of gap junction channel function. Am J Physiol Cell Physiol (2000) 1.44
A general analysis of the receptor-drug interaction. Br J Pharmacol Chemother (1966) 1.38
Neuropathology of early HIV-1 infection. Brain Pathol (1996) 1.37
Epidemiological patterns of foot-and-mouth disease worldwide. Transbound Emerg Dis (2008) 1.35
Search for neutrinoless double-beta decay in 136Xe with EXO-200. Phys Rev Lett (2012) 1.33
Neuronal nicotinic receptors in dementia with Lewy bodies and schizophrenia: alpha-bungarotoxin and nicotine binding in the thalamus. J Neurochem (1999) 1.33
Relationships between octanol-water partition coefficient and aqueous solubility. Environ Sci Technol (1985) 1.32
Quantification of the characteristics of antagonists exhibiting both competitive antagonism and functional interaction. Br J Pharmacol (1985) 1.29
Measuring brain stem and cerebellar damage in parkinsonian syndromes using diffusion tensor MRI. Neurology (2006) 1.27
The non-structural polyprotein 3ABC of foot-and-mouth disease virus as a diagnostic antigen in ELISA to differentiate infected from vaccinated cattle. Arch Virol (1997) 1.27
Combining dimensional and categorical representation of psychosis: the way forward for DSM-V and ICD-11? Psychol Med (2009) 1.27
The predictors of emphysema in South African gold miners. Am Rev Respir Dis (1987) 1.25
Baclofen (beta-p-chlorophenyl-gamma-aminobutyric acid) enhances [3H]gamma-aminobutyric acid (3H-GABA) release from rat globus pallidus in vitro. J Pharm Pharmacol (1978) 1.19
Coronary artery infusion of neuropeptide Y in patients with angina pectoris. Lancet (1987) 1.16
The use of the logarithmic transformation in the calculation of the transport parameters of a system that obeys Michaelis-Menten kinetics. Biochem J (1967) 1.12
Similarity between mu-opioid receptors in mouse vas deferens and guinea-pig ileum. Br J Pharmacol (1985) 1.11
Disruption of lens fiber cell architecture in mice expressing a chimeric AQP0-LTR protein. FASEB J (2000) 1.11
Air-surface exchange of polybrominated diphenyl ethers and polychlorinated biphenyls. Environ Sci Technol (2002) 1.10
Inhibition of intra-Golgi transport in vitro by mitotic kinase. J Biol Chem (1993) 1.10
Adenosine A2 receptor occupancy regulates stimulated neutrophil function via activation of a serine/threonine protein phosphatase. J Biol Chem (1996) 1.09
Pathological findings in mine workers: I. Description of the PATHAUT database. Am J Ind Med (1987) 1.08
Diffusion of labelled substances through isolated rat diaphragm. Br J Pharmacol (1971) 1.08
Independent dimensions of hyperactivity and aggression: a validation with playroom observation data. J Abnorm Psychol (1982) 1.07
Cortical selective vulnerability in motor neuron disease: a morphometric study. Brain (2004) 1.07
Psychopathological symptoms during interferon-alpha and ribavirin treatment: effects on virologic response. Mol Psychiatry (2005) 1.05
Assessing ADHD across settings: contributions of behavioral assessment to categorical decision making. J Clin Child Psychol (2001) 1.04
Abnormalities of Wnt signalling in schizophrenia--evidence for neurodevelopmental abnormality. Neuroreport (1998) 1.04
Correlating the physical-chemical properties of phthalate esters using the 'three solubility' approach. Chemosphere (2000) 1.03
A randomised controlled trial of cognitive behaviour therapy for psychosis in a routine clinical service. Acta Psychiatr Scand (2010) 1.02
Rate of onset and offset of neuromuscular block in the isolated rat diaphragm. Br J Pharmacol (1971) 1.01
An assessment of pancreatic endocrine function and insulin sensitivity in patients with transient neonatal diabetes in remission. Arch Dis Child Fetal Neonatal Ed (2004) 1.01
Mass transfer coefficient correlations for volatilization of organic solutes from water. Environ Sci Technol (1983) 1.01
Rediscovering monoamine oxidase inhibitors. BMJ (1989) 1.00
Randomised controlled trial of CD-ROM-based cognitive-behavioural self-care for bulimia nervosa. Br J Psychiatry (2008) 0.99
The use of multivariate statistical methods in psychiatry. Stat Methods Med Res (1998) 0.99
BETR North America: a regionally segmented multimedia contaminant fate model for North America. Environ Sci Pollut Res Int (2001) 0.98
Correlation of bioconcentration factors. Environ Sci Technol (1982) 0.97
Observation of two-neutrino double-beta decay in 136Xe with the EXO-200 detector. Phys Rev Lett (2011) 0.97
Glycogen synthase kinase-3beta immunoreactivity is reduced in the prefrontal cortex in schizophrenia. Neurosci Lett (2001) 0.96
Decreased expression of AMPA receptor messenger RNA and protein in AIDS: a model for HIV-associated neurotoxicity. Nat Med (1995) 0.96
Development of continental scale multimedia contaminant fate models: integrating GIS. Environ Sci Pollut Res Int (2001) 0.96
Guidelines for the diagnosis and management of neurological complications of HIV infection. Eur J Neurol (2004) 0.96
Predictors of psychological distress in carers of people with amyotrophic lateral sclerosis: a longitudinal study. Psychol Med (2006) 0.96
Randomised controlled trials of conventional antipsychotic versus new atypical drugs, and new atypical drugs versus clozapine, in people with schizophrenia responding poorly to, or intolerant of, current drug treatment. Health Technol Assess (2006) 0.96
Effects of combined carotid chemoreceptor and atrial receptor stimulation on renal blood flow in anaesthetized dogs. J Physiol (1983) 0.95
Group treatment of auditory hallucinations. Exploratory study of effectiveness. Br J Psychiatry (1999) 0.94
Passive and active air samplers as complementary methods for investigating persistent organic pollutants in the Great Lakes Basin. Environ Sci Technol (2005) 0.94
Fugacity revisited. Environ Sci Technol (1982) 0.94
Disturbance of Notch-1 and Wnt signalling proteins in neuroglial balloon cells and abnormal large neurons in focal cortical dysplasia in human cortex. Acta Neuropathol (1999) 0.94
A model of organic chemical uptake by plants from soil and the atmosphere. Environ Sci Technol (1994) 0.93
No evidence for links between autism, MMR and measles virus. Psychol Med (2004) 0.93
A test of the null equation for functional antagonism. Br J Pharmacol (1981) 0.93
High-temperature short-time heat inactivation of HIV and other viruses in human blood plasma. Vox Sang (1992) 0.92
Longitudinal predictors of psychological distress and self-esteem in people with ALS. Neurology (2006) 0.91
Evaporation rate of spills of hydrocarbons and petroleum mixtures. Environ Sci Technol (1984) 0.91
THE DETECTION AND SIGNIFICANCE OF MELANOPHORE EXPANDING SUBSTANCE IN URINE AND BLOOD WITH SPECIAL REFERENCE TO RETINITIS PIGMENTOSA. Br J Ophthalmol (1943) 0.91
[Action spectra for lethality in recombination-less strains of Salmonella typhimurium and Escherichia coli]. Photochem Photobiol (1976) 0.91
Progress and prospective of plant sterol and plant stanol research: report of the Maastricht meeting. Atherosclerosis (2012) 0.91
Mapping the genetic determinants of pathogenicity and plaque phenotype in swine vesicular disease virus. J Virol (1999) 0.90
Neuronal pattern correlates with the severity of human immunodeficiency virus-associated dementia complex. Usefulness of spatial pattern analysis in clinicopathological studies. Am J Pathol (1996) 0.90
Maturity onset diabetes of the young (MODY) and early onset Type II diabetes are not caused by loss of imprinting at the transient neonatal diabetes (TNDM) locus. Diabetologia (2001) 0.89
Quantification of the actions of agonists that simultaneously act on a particular type of receptor and have separate functional interactant properties. Br J Pharmacol (1986) 0.89
The clinical effectiveness and cost of repetitive transcranial magnetic stimulation versus electroconvulsive therapy in severe depression: a multicentre pragmatic randomised controlled trial and economic analysis. Health Technol Assess (2007) 0.88
Separation of the Baragwanath craniopagus twins. Br J Plast Surg (1991) 0.87
Twins discordant for schizophrenia: psychopathology of the non-schizophrenic co-twins. Acta Psychiatr Scand (2008) 0.87
The combined effects of unilateral enucleation and rearing in a "dim" red light on synapse-to-neuron ratios in the rat superior colliculus. J Comp Neurol (1987) 0.87
Evidence for the "grasshopper" effect and fractionation during long-range atmospheric transport of organic contaminants. Environ Pollut (2004) 0.87
Strategies for including vegetation compartments in multimedia models. Chemosphere (2001) 0.86
Anterior polar cataract: clinical spectrum and genetic linkage in a single family. Eye (Lond) (1998) 0.86
Model of the Long-Term Exchange of PCBs between Soil and the Atmosphere in the Southern U.K. Environ Sci Technol (1995) 0.86
Frequency, prevalence, incidence and risk factors associated with visual hallucinations in a sample of patients with Parkinson's disease: a longitudinal 4-year study. Int J Geriatr Psychiatry (2012) 0.85
Biological determinants of difficult to treat patients with schizophrenia. Br J Psychiatry Suppl (1996) 0.85
Complications of pregnancy and delivery and psychosis in adult life. BMJ (1991) 0.85
Calculating fugacity. Environ Sci Technol (1981) 0.85
A generally useful modification of ALLFIT that facilitates the fitting of null equations to dose-response curves. Trends Pharmacol Sci (1988) 0.85
Controlling persistent organic pollutants-what next? Environ Toxicol Pharmacol (1998) 0.85
DRD2 Ser311/Cys311 polymorphism in schizophrenia. Lancet (1994) 0.84